A carregar...
Simultaneous determination of newly developed antiviral agents in pharmaceutical formulations by HPLC-DAD
BACKGROUND: Ombitasvir/paritaprevir/ritonavir/dasabuvir (Viekira Pak(®)) are the newest medicines approved for use in the treatment of hepatitis C virus (HCV) and are available in tablet form as an oral combination. Specifically, these agents are indicated in the treatment of HCV in patients with ge...
Na minha lista:
| Publicado no: | Chem Cent J |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5214962/ https://ncbi.nlm.nih.gov/pubmed/28101128 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13065-016-0232-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|